Literature DB >> 12142128

ACC/AHA/NHLBI clinical advisory on the use and safety of statins.

Richard C Pasternak, Sidney C Smith, C Noel Bairey-Merz, Scott M Grundy, James I Cleeman, Claude Lenfant.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12142128     DOI： 10.1016/s0735-1097(02)02030-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  120 in total

Review 1.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

Review 2.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 3.  Pharmacoeconomics of lipid-lowering drugs.

Authors:  Dean G Smith
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

Review 4.  Toxicity of antilipidemic agents: facts and fictions.

Authors:  Antonios M Xydakis; Peter H Jones
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

5.  Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine.

Authors:  Michelle R Adams; Eddy Konaniah; James G Cash; David Y Hui
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

6.  Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.

Authors:  Bradley W Blaser; Haesook T Kim; Edwin P Alyea; Vincent T Ho; Corey Cutler; Philippe Armand; John Koreth; Joseph H Antin; Jorge Plutzky; Robert J Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-11       Impact factor: 5.742

7.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 8.  Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story.

Authors:  Emma A Meagher
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 9.  Best practice in primary care pathology: review 1.

Authors:  W S A Smellie; D Wilson; C A M McNulty; M J Galloway; G A Spickett; D I Finnigan; D A Bareford; M A Greig; J Richards
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 10.  New insights in the treatment of dyslipidemia: a focus on cardiovascular event reduction and the anti-atherosclerotic effects of atorvastatin.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.